MAPT and Alzheimer disease: The clinical measures (including MMSE score, ADAS-cog11 score, ADAS-cog13 score, CSF Aβ level, CSF Tau level, CSF p-Tau level, AVLT score, and FDG) were significantly different among the NC, MCI, and AD groups (P < 0.001 with ANOVA; Table 1).